# decision_prep_memo.md - Microsoft / MSFT

## Handoff metadata
- Artifact: `decision_prep_memo.md`
- Subject: Microsoft Corporation (`MSFT`), Nasdaq common stock
- Scope: IC-stage gate-aware decision preparation for MSFT; non-final because portfolio, valuation, risk, and freshness gates remain Limited
- Owner: Investment Committee Agent
- Producing agent/skill/workflow: Investment Committee Agent / Investment Committee Synthesis / Equity internal full workflow
- Workflow: Equity internal full workflow / Agent workflow with spawned subagents
- Execution mode: Agent workflow with spawned subagents
- As-of date/time: price snapshot 2026-06-29 21:57:01 UTC; synthesis 2026-06-30 Europe/Budapest runtime context
- Output status: Limited
- Evidence status: Limited; public evidence is usable for decision preparation but not sufficient for final IC Action
- Freshness status: Current runtime snapshot for provided quote timestamp and FY26 Q3 evidence; source durability Limited for quote/news; final freshness lock required before final IC memo
- Source scope: public data only; Microsoft IR FY26 Q3 materials, SEC Form 10-Q reference, market quote snapshot, public news/risk checks
- Evidence limits: no paid consensus; no full 10-Q note extraction; no independent customer/channel checks; valuation and risk handoffs remain Limited; portfolio data missing
- Key limitations: portfolio fit is not personalized; valuation stress is incomplete; AI capex ROI risk is not fully cleared; no final IC Action
- Key findings: Microsoft is a high-quality large-cap growth company, but the setup requires valuation, AI capex ROI, risk, and portfolio gates before any final action
- Missing gates: Portfolio context, upgraded valuation gate, upgraded risk gate, final evidence/freshness lock
- Decision boundary: Non-final IC preparation artifact only; no `Action Box`; no final buy/sell/hold/add/trim/initiate language
- Decision constraints: `IC Action Status: Limited`; exact trade instructions and exact sizing are prohibited
- Downstream handoff: To `final_investment_memo.md` only after missing gates are closed
- Required follow-up: Collect portfolio context; rerun valuation stress; complete risk-red-team stress tests; refresh evidence and market data before any final IC-stage artifact

## IC metadata

- Request type: Agent workflow with spawned subagents live smoke test.
- Produced by: Investment Committee Agent / Investment Committee Synthesis.
- Analysis Status: Limited.
- IC Action Status: Limited.
- Decision Confidence: Medium for non-final decision preparation; not a forecast certainty.
- Time Horizon: 3+ years.
- Decision mode assumptions: new potential `MSFT` exposure, no current position, missing portfolio details.
- Consumed handoff artifacts: `evidence_pack.md`; `equity_company_analysis.md`; `financial_statement_analysis.md`; `valuation_expectations.md`; `risk_red_team.md`; `portfolio_fit.md`; `agent_workflow_audit.md`.

Execution mode: Agent workflow with spawned subagents

## Runtime Execution Plan

The request was classified as a concrete public-equity investment-action request for Microsoft with no current position and a 3+ year horizon. The user explicitly requested a spawned-subagent workflow, so `Agent workflow with spawned subagents` was permitted and actually used. The final artifact is `decision_prep_memo.md`: the analysis is sufficient for decision preparation, but not for a final IC Action.

### Actually spawned and consumed subagents

| Agent / module | Subagent | Handoff artifact | Status |
|---|---|---|---|
| Evidence Collector Agent | Dewey / `019f1567-4638-73a1-a793-d2dc9cdff83f` | `evidence_pack.md` | Limited |
| Equity Agent | Turing / `019f1567-978d-7de1-aa38-baaff129ca77` | `equity_company_analysis.md` | Complete |
| Financial Statement Analysis contributor | Wegener / `019f1567-d6f2-7f30-9033-6d6b1858122b` | `financial_statement_analysis.md` | Complete |
| Valuation & Expectations Agent | Copernicus / `019f1568-1442-7e61-9c6e-451288afc0bb` | `valuation_expectations.md` | Limited |
| Risk / Red Team Agent | Pascal / `019f1568-60ac-7642-ace4-9a07b587add2` | `risk_red_team.md` | Limited |
| Portfolio Fit Agent | Dirac / `019f1568-a840-78c1-b523-ceaf6eb101fd` | `portfolio_fit.md` | Limited |
| Investment Committee Agent | James / `019f156e-5b8c-7301-824e-efc7f8420c4e` | `decision_prep_memo.md` synthesis | Limited |

The run audit is stored in `agent_workflow_audit.md`.

### Module status table

| Module | Status | Reason / limitation |
|---|---:|---|
| Master Intake Router | Complete | Request: `MSFT`, possible new position, 3+ year horizon, explicit spawned-subagent workflow. |
| Asset Intake Router | Complete | `MSFT` identified as Nasdaq common stock; route is Equity internal full workflow. |
| Evidence Collector | Limited | Public evidence usable; no paid consensus, no full 10-Q note extraction, no final evidence lock. |
| Equity Company Analysis | Complete | Business quality and thesis durability assessed; stock attractiveness not decided. |
| Financial Statement Analysis | Complete | FY26 Q3 shows strong growth; capex/FCF and lease/tax watch items passed downstream. |
| Valuation & Expectations | Limited | Incomplete return bridge; current valuation requires durable EPS growth and AI payoff. |
| Risk / Red Team | Limited | Risk gate is conditional; AI capex ROI, margin, regulatory, cybersecurity, and multiple-compression stress tests remain open. |
| Portfolio Fit | Limited | No holdings, goal, risk tolerance, ETF/index overlap, concentration, tax, or currency context. |
| Implementation / vehicle quality | Not material | Ordinary Nasdaq common stock; no wrapper, option, fund, structured note, or private vehicle specified. |
| Optional sector/news/macro/positioning modules | Skipped with reason | Key news and risk facts were captured in evidence/risk; separate modules can be added before a final memo if IC deems them material. |
| IC Synthesis | Limited | Uses a Decision-Prep Box, not an Action Box. |

## Decision-Prep Box

**Working conclusion:** Microsoft appears to be a high-quality U.S. large-cap growth company with a strong cloud and enterprise software platform. Investment readiness is not finalized: the current valuation already embeds durable earnings growth and AI investment payoff, and personal portfolio fit is unknown.

**IC Action Status:** Limited. A final `IC Action` is not authorized.

**What can be concluded now:**

- Business quality is high, supported by Microsoft Cloud, Azure, Microsoft 365, Copilot, Dynamics, GitHub/security, and enterprise distribution.
- FY26 Q3 was strong: revenue $82.9B, operating income $38.4B, net income $31.8B, diluted EPS $4.27, Microsoft Cloud $54.5B (+29%), and Azure and other cloud services +40%.
- Operating cash flow remains large, but free-cash-flow conversion is pressured by infrastructure spending: operating cash flow was $46.7B and property/equipment additions were $30.9B in the quarter.
- The main analytical fork is whether Microsoft can convert AI capex into profitable cloud and application revenue while stabilizing cloud margins and free-cash-flow conversion.

**What limits the conclusion:** current valuation may not offer enough margin of safety; AI revenue may not fully offset infrastructure cost growth; the user's portfolio may already contain large Microsoft exposure; regulatory, cybersecurity, OpenAI economics, and data-center constraints remain relevant.

**Missing gates:** personal portfolio fit; valuation stress; AI capex ROI bridge; risk completion; final freshness lock.

## Why `decision_prep_memo.md` was selected

`decision_prep_memo.md` is the correct gate-aware artifact because the workflow produced a usable public evidence base and specialist handoffs for decision preparation, but not enough to support a final action. Portfolio context is the primary final-action blocker and the canonical Decision-Prep trigger for this possible new-position request. Valuation, risk, and freshness are additional limiting gates: they remain `Limited` and independently prohibit a final positive IC Action. `evidence_gap_memo.md` is not primary because evidence is usable rather than blocking; `limited_ic_draft.md` would be defensible if valuation/risk were the dominant artifact-selection driver, but `decision_prep_memo.md` is more precise here because the request is a new-position decision-preparation case with missing portfolio context.

## Consumed handoff artifacts

| Artifact | Owner | Output status | Evidence / freshness status | Key limitation carried into IC |
|---|---|---:|---|---|
| `evidence_pack.md` | Evidence Collector Agent | Limited | Current runtime quote/news snapshot; recent FY26 Q3; public data only; source durability Limited for quote/news | No paid consensus, no full 10-Q note extraction, no final evidence lock |
| `equity_company_analysis.md` | Equity Agent | Complete | Sufficient for business-quality scope | Business quality does not equal stock attractiveness |
| `financial_statement_analysis.md` | FSA contributor | Complete | Official public filings sufficient for scoped method | Capex/FCF, lease, tax, and accounting watch items need valuation/risk treatment |
| `valuation_expectations.md` | Valuation & Expectations Agent | Limited | Current public market data; public estimates are source-limited | Incomplete return bridge; no final target price |
| `risk_red_team.md` | Risk / Red Team Agent | Limited | Public-data risk review | Conditional risk gate; AI capex ROI and multiple-compression stress needed |
| `portfolio_fit.md` | Portfolio Fit Agent | Limited | Structural view only | Personal suitability not determined |

## Source and freshness table

| Source | Retrieval timestamp | Data period | Supports | Limitation | Permitted downstream use |
|---|---:|---|---|---|---|
| Market quote / finance feed | 2026-06-29 21:57:01 UTC | Latest quote | Price $368.57, market cap about $2.744T, P/E about 21.94 | Provider timing and rounding differences | Valuation snapshot; refresh before final memo |
| Microsoft FY26 Q3 press release | 2026-06-30 runtime | Quarter ended 2026-03-31; released 2026-04-29 | Revenue, operating income, net income, EPS, cloud/Azure growth | Company-reported quarterly data | Reported operating claims |
| Microsoft FY26 Q3 cash flows | 2026-06-30 runtime | Quarter and nine months ended 2026-03-31 | Operating cash flow and property/equipment additions | Does not prove capex ROI | FCF/capex bridge input |
| Microsoft FY26 Q3 balance sheet | 2026-06-30 runtime | As of 2026-03-31 | Cash, investments, debt, assets/liabilities | Interim snapshot | Liquidity and balance-sheet input |
| Microsoft FY26 Q3 Form 10-Q / SEC | 2026-06-30 runtime | Quarter ended 2026-03-31 | Filing-backed legal, tax and accounting context | Full note extraction not completed | Risk/accounting follow-up |
| Recent public news | 2026-06-30 runtime | Mainly June 2026 | AI capex concern, power/water constraints, regulatory scrutiny | Not exhaustive monitoring | Risk flags for follow-up |

## What would move this to `final_investment_memo.md`

1. The user provides minimum portfolio context.
2. Valuation becomes Complete through EPS CAGR, margin, free-cash-flow conversion, and P/E compression scenarios.
3. Risk Red Team becomes Complete through AI capex ROI and key thesis-breaker stress tests.
4. Evidence Collector performs a pre-IC evidence lock with current price, latest filing/earnings/news checks.
5. IC confirms that implementation constraints are not material or are closed.

## Primary source links

- Microsoft FY26 Q3 press release: https://www.microsoft.com/en-us/Investor/earnings/FY-2026-Q3/press-release-webcast
- Microsoft FY26 Q3 cash flows: https://www.microsoft.com/en-us/Investor/earnings/FY-2026-Q3/cash-flows
- Microsoft FY26 Q3 balance sheets: https://www.microsoft.com/en-us/Investor/earnings/FY-2026-Q3/balance-sheets
- Microsoft FY26 Q3 segment results: https://www.microsoft.com/en-us/Investor/earnings/FY-2026-Q3/segment-revenues
- Microsoft FY26 Q3 SEC filing reference: https://www.sec.gov/Archives/edgar/data/789019/000119312526191507/msft-20260331.htm

## Structured handoff

- Artifact: `decision_prep_memo.md`
- Subject: Microsoft Corporation (`MSFT`), Nasdaq common stock
- Scope: IC-stage gate-aware decision preparation for MSFT; non-final because portfolio, valuation, risk, and freshness gates remain Limited
- Owner: Investment Committee Agent
- Producing agent/skill/workflow: Investment Committee Agent / Investment Committee Synthesis / Equity internal full workflow
- Workflow: Equity internal full workflow / Agent workflow with spawned subagents
- Execution mode: Agent workflow with spawned subagents
- As-of date/time: price snapshot 2026-06-29 21:57:01 UTC; synthesis 2026-06-30 Europe/Budapest runtime context
- Output status: Limited
- Evidence status: Limited; public evidence is usable for decision preparation but not sufficient for final IC Action
- Freshness status: Current runtime snapshot for provided quote timestamp and FY26 Q3 evidence; source durability Limited for quote/news; final freshness lock required before final IC memo
- Source scope: public data only; Microsoft IR FY26 Q3 materials, SEC Form 10-Q reference, market quote snapshot, public news/risk checks
- Evidence limits: no paid consensus; no full 10-Q note extraction; no independent customer/channel checks; valuation and risk handoffs remain Limited; portfolio data missing
- Key limitations: portfolio fit is not personalized; valuation stress is incomplete; AI capex ROI risk is not fully cleared; no final IC Action
- Key findings: Microsoft is a high-quality large-cap growth company, but the setup requires valuation, AI capex ROI, risk, and portfolio gates before any final action
- Missing gates: Portfolio context, upgraded valuation gate, upgraded risk gate, final evidence/freshness lock
- Decision boundary: Non-final IC preparation artifact only; no `Action Box`; no final buy/sell/hold/add/trim/initiate language
- Decision constraints: `IC Action Status: Limited`; exact trade instructions and exact sizing are prohibited
- Downstream handoff: To `final_investment_memo.md` only after missing gates are closed
- Required follow-up: Collect portfolio context; rerun valuation stress; complete risk-red-team stress tests; refresh evidence and market data before any final IC-stage artifact

